Rapt Therapeutics News and Activities

Rapt Therapeutics is a company listed under the stock ticker RAPT (US).

Acquisition, funding and merger involving Rapt Therapeutics.

• GSK has announced the acquisition of Rapt Therapeutics  (posted on January 21 2026).

View the org chart displaying its 31 main executives

Most searched biographies at Rapt Therapeutics

• Brian Wong, Chief Executive Officer and Director
• Wendye Robbins, Director
• Linda Kozick, Director

Popular executive movements at Rapt Therapeutics

• William Ho, Chief Medical Officer, will leave the company on Dec. 31, 2025  (posted on December 1 2025).

Create your alert
to follow the executive moves at Rapt Therapeutics.

Rapt Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Rapt Therapeutics

• RAPT Therapeutics Announces Private Placement Financing of $50 Million | RAPT Therapeutics, Inc.
• RAPT Therapeutics Announces Initiation of Phase 2b Trial of RPT193 in Patients with Moderate-to-Severe Atopic Dermatitis | RAPT Therapeutics, Inc.
• RAPT Therapeutics Reports First Quarter 2022 Financial Results | RAPT Therapeutics, Inc.
• RAPT Therapeutics Expands Leadership Team with Multiple Key Hires | RAPT Therapeutics, Inc.
• RAPT Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results | RAPT Therapeutics, Inc.
• RAPT Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference | RAPT Therapeutics, Inc.
• RAPT Therapeutics to Participate in the 11th Annual SVB Leerink Healthcare Conference | RAPT Therapeutics, Inc.
• RAPT Therapeutics Announces Biomarker Data from Phase 1b Trial of RPT193 Consistent with Disease Modification in Atopic Dermatitis | RAPT Therapeutics, Inc.
• RAPT Therapeutics Appoints Lisa Butterfield, Ph.D., and Lawrence Fong, M.D., to Scientific Advisory Board | RAPT Therapeutics, Inc.
• RAPT Therapeutics to Present at Upcoming Virtual Investor Conferences | RAPT Therapeutics, Inc.
• View more press releases Close

Social media about Rapt Therapeutics

• Rapt Therapeutics on Wikipedia, Google News & Yahoo Finance
• Rapt Therapeutics on LinkedIn, X (Twitter) & YouTube